HGC Investment Management’s LakeShore Biopharma Warrants LSBPW Stock Holding History

HGC Investment Management’s Portfolio LSBPW Stock Details LSBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,000	Closed	-$35	–	179
2025 Q4	$35	Hold	5,000	–	–	﹤0.01%	159
2025 Q3	$25	Hold	5,000	–	–	﹤0.01%	123
2025 Q2	$200	Hold	5,000	–	–	﹤0.01%	99
2025 Q1	$206	Hold	5,000	–	–	﹤0.01%	75
2024 Q4	$397	Hold	5,000	–	–	﹤0.01%	63
2024 Q3	$331	Hold	5,000	–	–	﹤0.01%	96
2024 Q2	$440	Hold	5,000	–	–	﹤0.01%	93
2024 Q1	$358	Hold	5,000	–	–	﹤0.01%	87
2023 Q4	$190	Hold	5,000	–	–	﹤0.01%	90
2023 Q3	$206	Hold	5,000	–	–	﹤0.01%	129
2023 Q2	$1K	Hold	5,000	–	–	﹤0.01%	142
2023 Q1	$1K	Buy	+5,000	New	+$758	﹤0.01%	216

Other funds holding LSBPW

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

HGC Investment Management's LSBPW Position: Q1 2026 in Review

HGC Investment Management sold out of LakeShore Biopharma Warrants (LSBPW) in Q1 2026, closing a stake of 5,000 shares — an estimated $35 sold.

HGC Investment Management first reported a position in LSBPW in Q1 2023 and held it in 12 quarters. The position peaked at $1K in Q2 2023. 2 funds tracked by Wall St. Rank hold LSBPW as of Q1 2026.

HGC Investment Management reported no remaining LakeShore Biopharma Warrants position as of Q1 2026 after selling out during the quarter.
HGC Investment Management sold 5,000 LakeShore Biopharma Warrants shares in Q1 2026, an estimated $35.
HGC Investment Management first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 12 quarters.
HGC Investment Management's LakeShore Biopharma Warrants position peaked at $1K in Q2 2023.
2 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q1 2026.

Based on HGC Investment Management's 13F filing for Q1 2026, filed 15 May 2026.